Skip to content
Disclosery

Nextech Invest Ltd.

Follow

13F filer, CIK 1595430, Zurich, Switzerland

Nextech Invest Ltd. reported $656,977,659 across 15 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 96.41% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001595430-25-000007

Period
2025-09-30
Reported value
$657M
Holdings
15
Top 10 weight
96.41%
New
1
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MERSANA THERAPEUTICS INCnew+482,689$3.75M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CARGO THERAPEUTICS INC COMexited-2,642,502-$10.9M
Mersana Therapeutics Incexited-12,067,246-$3.57M
SPRYreduced-81,026-$814K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001595430-25-000007, largest first. % of portfolio is the value over $656,977,659, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 7,601,087 shares; 2025Q2: 7,601,087 shares; 2025Q3: 7,601,087 shares 7,601,087$355M54.03%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 5,285,714 shares; 2025Q2: 7,162,637 shares; 2025Q3: 7,162,637 shares 7,162,637$86M13.08%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 4,055,861 shares; 2025Q2: 4,055,861 shares; 2025Q3: 4,055,861 shares 4,055,861$56.7M8.64%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 5,533,980 shares; 2025Q2: 5,533,980 shares; 2025Q3: 5,533,980 shares 5,533,980$46.5M7.08%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 3,846,409 shares; 2025Q2: 3,846,409 shares; 2025Q3: 3,846,409 shares 3,846,409$20.1M3.06%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: 340,909 shares; 2025Q3: 340,909 shares 340,909$19.3M2.94%0Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,113,946 shares; 2025Q2: 1,113,946 shares; 2025Q3: 1,113,946 shares 1,113,946$19M2.9%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,408,394 shares; 2025Q2: 1,408,394 shares; 2025Q3: 1,408,394 shares 1,408,394$12M1.83%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,476,998 shares; 2025Q2: 2,915,998 shares; 2025Q3: 2,915,998 shares 2,915,998$11.6M1.77%0Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 7,419,355 shares; 2025Q2: 7,419,355 shares; 2025Q3: 7,419,355 shares 7,419,355$7.19M1.09%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,141,145 shares; 2025Q2: 1,141,145 shares; 2025Q3: 1,141,145 shares 1,141,145$6.77M1.03%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 936,729 shares; 2025Q2: 741,729 shares; 2025Q3: 660,703 shares 660,703$6.64M1.01%-81,026Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 952,400 shares; 2025Q2: 952,400 shares; 2025Q3: 952,400 shares 952,400$4.94M0.75%0Timeline
MERSANA THERAPEUTICS INCMERSANA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 482,689 shares 482,689$3.75M0.57%new
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,228,069 shares; 2025Q2: 1,228,069 shares; 2025Q3: 1,228,069 shares 1,228,069$1.51M0.23%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COM2,642,502$10.9Mshares
Mersana Therapeutics IncMersana Therapeutics Inc12,067,246$3.57Mshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001595430-25-000007 base2025-11-14acceptance time not in the bulk data set